CORT
Corcept Therapeutics Inc
Price:  
21.66 
USD
Volume:  
899,427.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CORT WACC - Weighted Average Cost of Capital

The WACC of Corcept Therapeutics Inc (CORT) is 8.2%.

The Cost of Equity of Corcept Therapeutics Inc (CORT) is 12.20%.
The Cost of Debt of Corcept Therapeutics Inc (CORT) is 5.00%.

Range Selected
Cost of equity 10.40% - 14.00% 12.20%
Tax rate 16.00% - 18.60% 17.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.3% - 9.0% 8.2%
WACC

CORT WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.36 1.58
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.40% 14.00%
Tax rate 16.00% 18.60%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.3% 9.0%
Selected WACC 8.2%